Uptake of new treatment strategies for deep vein thrombosis: An international audit

International Journal for Quality in Health Care

Volumn 16, Issue 3, 2004, Pages 193-200

  Aujesky, Drahomir A ^a   Cornuz, Jacques ^a   Bosson, Jean Luc ^b   Bounameaux, Henri ^c   Emmerich, Joseph ^d   Hull, Russell D ^e   Mackay, Elizabeth ^e   Perrier, Arnaud ^c   Quan, Hude ^f   Tsuyuki, Ross T ^g   Ghali, William A ^e  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anticoagulation; Deep vein thrombosis; Low molecular weight heparins; Practice variation; Process of care

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; CANADA; COMORBIDITY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; MEDICAL RECORD; OUTPATIENT DEPARTMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAMPLING; SWITZERLAND; TEACHING HOSPITAL; TREATMENT PLANNING;

AGED; AMBULATORY CARE; ANTICOAGULANTS; CANADA; FEMALE; FRANCE; HEALTH SERVICES RESEARCH; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; PATIENT CARE; SWITZERLAND; VENOUS THROMBOSIS;

EID: 2942735030     PISSN: 13534505     EISSN: None     Source Type: Journal    
DOI: 10.1093/intqhc/mzh039     Document Type: Review

References (17)

1. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized controlled trials. Ann Intern Med 1999; 130: 800-809.
2. Gould MK, Dembitzer AD, Sanders GD, Garber AM. Low molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med 1999; 130: 789-799.
3. Koopman MMW, Prandoni P, Piovella F et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334: 682-687.
4. Levine M, Gent M, Hirsh J et al. A comparison of low-molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for deep-vein thrombosis. N Engl J Med 1996; 334: 677-681.
5. Boccalon H, Elias A, Chalé JJ, Cadène A, Gabriel S for the Vascular Midi-Pyrenees Network Group. Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with low-molecular-weight heparin. Arch Intern Med 2000; 160: 1769-1773.
6. Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch Intern Med 1998; 158: 2001-2003.
7. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. J Am Med Assoc 1992; 268: 240-248.
8. Wennberg J, Gittelsohn A. Variations in medical care among small areas. Sci Am 1982; 246: 120-134.
9. Mc Pherson K, Wennberg JE, Hovind OB, Clifford P. Small area variations in the use of common surgical procedures: An international comparison of New England, England, and Norway. N Engl J Med 1982; 307: 1310-1314.
10. Dawson JH. Practice variations: A challenge for physicians. J Am Med Assoc 1987; 258: 2570.
11. Chin MH, Wang JC, Zhang JX, Lang RM. Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. J Gen Intern Med 1997; 12: 563-566.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373-383.
13. Low molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med 1997; 337: 657-662.
14. Simonneau G, Sors H, Charbonnier B et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-669.
15. Hull RD, Raskob GE, Brant RF et al. Low-molecular weight heparin vs heparin in the treatment of patients with pulmonary embolism. American-Canadian Thrombosis Study Group. Arch Intern Med 2000; 160: 229-236.
16. Campbell SE, Walker AE, Grimshaw JM et al. The prevalence of prophylaxis for deep vein thrombosis in acute hospital trusts. Int J Qual Health Care 2001; 13: 309-316.
17. Donabedian A. Quality of care. How can it be assessed? J Am Med Assoc 1988; 260:1743-1748.